Menu Search
Equities

Fresenius Medical Care AG

FMEX:GER

Fresenius Medical Care AG

Actions
Health CareHealth Care Providers
  • Price (EUR)41.44
  • Today's Change0.64 / 1.57%
  • Shares traded315.07k
  • 1 Year change+15.46%
  • Beta0.8267
Data delayed at least 15 minutes, as of Nov 21 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy1
Outperform3
Hold12
Sell4
Strong Sell2

Share price forecast in EUR

The 21 analysts offering 12 month price targets for Fresenius Medical Care AG have a median target of 39.00, with a high estimate of 52.00 and a low estimate of 22.80. The median estimate represents a -5.89% decrease from the last price of 41.44.
High25.5%52.00
Med-5.9%39.00
Low-45.0%22.80

Dividends in EUR

In 2023, Fresenius Medical Care AG reported a dividend of 1.19 EUR, which represents a 6.25% increase over last year. The 18 analysts covering the company expect dividends of 1.15 EUR for the upcoming fiscal year, a decrease of 3.78%.
Div growth (TTM)6.25%
More ▼

Earnings history & estimates in EUR

On Nov 05, 2024, Fresenius Medical Care AG reported 3rd quarter 2024 earnings of 0.82 per share. This result exceeded the 0.65 consensus of the 6 analysts covering the company and exceeded last year's 3rd quarter results by 43.86%.
The next earnings announcement is expected on Feb 25, 2025.
Average growth rate+12.52%
Fresenius Medical Care AG reported annual 2023 earnings of 2.58 per share on Feb 20, 2024.
Average growth rate-12.53%
More ▼

Revenue history & estimates in EUR

Fresenius Medical Care AG & Co. KGaA had 3rd quarter 2024 revenues of 4.76bn. This missed the 4.93bn consensus estimate of the 10 analysts following the company. This was 1.19% above the prior year's 3rd quarter results.
Average growth rate-0.87%
Fresenius Medical Care AG & Co. KGaA had revenues for the full year 2023 of 19.45bn. This was 0.29% above the prior year's results.
Average growth rate+2.81%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.